Owlet Inc
$ 13.66
4.12%
04 Dec - close price
- Market Cap 377,205,000 USD
- Current Price $ 13.66
- High / Low $ 13.84 / 12.99
- Stock P/E N/A
- Book Value -3.28
- EPS -2.81
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.10 %
- ROE -9.01 %
- 52 Week High 13.84
- 52 Week Low 2.75
About
None
Analyst Target Price
$14.88
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-14 | 2025-08-07 | 2025-05-08 | 2025-03-05 | 2024-11-13 | 2024-08-12 | 2024-05-06 | 2024-03-07 | 2023-11-13 | 2023-08-14 | 2023-05-11 | 2023-03-15 |
| Reported EPS | 0.03 | -2.53 | 0.11 | -0.07 | 0.03 | -0.3045 | -0.39 | -0.12 | -0.7 | -0.56 | -0.08 | -0.14 |
| Estimated EPS | -0.1967 | 0.1 | 0.04 | -0.48 | -0.24 | -0.19 | -0.14 | -0.04 | -0.36 | -0.37 | -0.09 | -0.15 |
| Surprise | 0.2267 | -2.63 | 0.07 | 0.41 | 0.27 | -0.1145 | -0.25 | -0.08 | -0.34 | -0.19 | 0.01 | 0.01 |
| Surprise Percentage | 115.2517% | -2630% | 175% | 85.4167% | 112.5% | -60.2632% | -178.5714% | -200% | -94.4444% | -51.3514% | 11.1111% | 6.6667% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OWLT
2025-10-19 21:32:39
Owlet, Inc. (NYSE: OWLT) has launched its medically-certified Dream Sock™ in South Africa, marking its expansion into Africa as a Class C Medical Device with CE Marking. This device allows parents to monitor their baby's vital signs and sleep patterns, providing real-time health notifications. The expansion aims to make hospital-grade monitoring more accessible globally, with Dream Sock available through various retailers and eligible for medical aid reimbursement in South Africa.
2025-10-19 21:32:39
The article indicates that Owlet shareholders have approved amendments to the company's charter and incentive plan during their annual meeting. However, due to an application error, the full content of the article detailing these approvals and their implications is not available.
2025-10-19 21:32:39
Owlet, Inc.'s Board of Directors has approved a 1-for-14 reverse stock split of its Class A common stock, effective July 7, 2023, with trading on a split-adjusted basis beginning July 10, 2023. This action is intended to help the company regain compliance with NYSE's minimum $1.00 average closing price requirement. The split will reduce the number of outstanding shares from approximately 118 million to 8.4 million and authorized shares from 1 billion to 107 million.
2025-10-17 03:29:26
Owlet, Inc., a smart infant monitoring company, has received approval from India's Central Drugs Standard Control Organization (CDSCO) for its Dream Sock device. This approval paves the way for Owlet to launch its integrated monitoring devices, including Dream Sock, Dream Sight, and Dream Duo, in India in early 2026, targeting a significant market with high birth rates and increasing digital adoption. The company aims to support new parents with clinically validated insights and early detection tools to improve infant health outcomes.
2025-10-16 05:37:31
Owlet has secured CDSCO approval for its Dream Sock and plans its expansion into India in early 2026. This move positions Owlet as one of the few infant health technology companies meeting India's strict medical device requirements, targeting a market with over 23 million expected births in 2025. The company will introduce its Dream Sock, Dream Sight, and Dream Duo products, aiming to improve infant health outcomes and empower parents with advanced monitoring tools.
2025-10-15 20:26:37
The provided content indicates an application error. Therefore, no information about Owlet receiving approval to launch infant monitoring products in India can be extracted or summarized from this page.
